This article refers to:
Article title: Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review
Authors: Briere J-B., Bowrin K., Coleman C., Fauchier L., Levy P., Folkerts K., Toumi M., Taieb V., Millier A., & Wu O.
Journal: Expert Review of Pharmacoeconomics & Outcomes Research
Bibliometrics: Volume 19, Number 1, pages 27 - 36
DOI: http://dx.doi.org/10.1080/14737167.2018.1518134
When the above article was first published online, texts in the article and Tables 1 to 5 contained some errors which have now been corrected.